Actual Medicinal Product (AMP) Ropinirole 1mg tablets (Viatris UK Healthcare Ltd)
Stability Information
- Stability
-
Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
No special requirements for storage.
- Provenance
-
This compatibility recommendation is derived from ReQuip tablets (GlaxoSmithKline UK Ltd).
- Generic
- Ropinirole
- Formulation
- Ropinirole 1mg tablets
-
Ropinirole
-
Ropinirole 1mg tablets
-
Ropinirole 1mg tablets (Viatris UK Healthcare Ltd)
-
-
ReQuip 1mg tablets (GlaxoSmithKline UK Ltd)
Ropinirole 500microgram tablets